Home>
US Stocks>
Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals Inc share price today

(ATNM)

Actinium Pharmaceuticals Inc share price is $1.36 & ₹115.18 as on 7 Dec 2024, 2.30 'hrs' IST

$1.36

▲

0.14

(11.48%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Actinium Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Actinium Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Actinium Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Actinium Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Actinium Pharmaceuticals Inc's financials.

Actinium Pharmaceuticals Inc share price movements

$1.20
$1.36
$1.36
11.76%
Downside
Day's Volatility :11.76%
Upside
0.0%
$1.19
$10.24
$1.36
12.5%
Downside
52 Weeks Volatility :88.38%
Upside
86.72%

Actinium Pharmaceuticals Inc Returns

Period	Actinium Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-33.33%	0.0%
6 Months	-84.73%	0.0%
1 Year	-77.07%	0.0%
3 Years	-83.45%	-21.5%

Actinium Pharmaceuticals Inc Key Statistics

in dollars & INR

Previous Close	$1.22
Open	$1.24
Today's High	$1.36
Today's Low	$1.2
Market Capitalization	$38.1M
Today's Volume	$354.0K
52 Week High	$10.24
52 Week Low	$1.19
Revenue TTM	$81.0K
EBITDA	$-46.5M
Earnings Per Share (EPS)	$-1.39
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-87.96%

How to invest in Actinium Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Actinium Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Actinium Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Actinium Pharmaceuticals Inc or ATNM on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Actinium Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Actinium Pharmaceuticals Inc shares which would translate to 0.623 fractional shares of Actinium Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Actinium Pharmaceuticals Inc

-60%

Period: Sep 7, 2024 to Dec 6, 2024. Change in 30 Days versus previous period

Search volume for Actinium Pharmaceuticals Inc on INDmoney from India has reduced in the last 30 days as on Dec 7, 2024. -60% less investors are searching Actinium Pharmaceuticals Inc in the last 30 days versus the previous period.

Analyst Recommendation on Actinium Pharmaceuticals Inc

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Actinium Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Actinium Pharmaceuticals Inc

What analysts predicted

Upside of 267.65%

Current:

$1.36

Target:

$5.00

Insights on Actinium Pharmaceuticals Inc

Decreasing Revenue
Revenue is down for the last 2 quarters, 114.0K → 81.0K (in $), with an average decrease of 29.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -8.67M → -11.56M (in $), with an average decrease of 16.4% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 42.1% return, outperforming this stock by 119.1%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.7% return, outperforming this stock by 122.4%

Actinium Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Actinium Pharmaceuticals Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Actinium Pharmaceuticals Inc Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Actinium Pharmaceuticals Inc	-33.33%	-84.73%	-77.07%	-83.45%	-82.67%
Regeneron Pharmaceuticals, Inc.	-6.86%	-23.34%	-8.6%	17.41%	110.02%
Biontech Se	10.16%	21.29%	14.9%	-59.29%	309.79%
Alnylam Pharmaceuticals, Inc.	-7.5%	64.08%	48.09%	42.33%	108.61%
Vertex Pharmaceuticals Incorporated	-8.46%	-4.83%	31.35%	122.6%	109.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Actinium Pharmaceuticals Inc	NA	NA	0.0	-1.42	-0.88	-0.31	NA	1.32
Regeneron Pharmaceuticals, Inc.	18.56	18.56	1.12	44.92	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.06	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Actinium Pharmaceuticals Inc	Buy	$38.1M	-82.67%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$82.9B	110.02%	18.56	33.61%
Biontech Se	Buy	$28.5B	309.79%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$32.7B	108.61%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$118.4B	109.65%	32.84	-4.51%

About Actinium Pharmaceuticals Inc

actinium pharmaceuticals, inc. (www.actiniumpharma.com) (nyse mkt: atnm) is a new york-based biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. actinium's targeted radiotherapy is based on its proprietary delivery platform for the therapeutic utilization of alpha-emitting actinium-225 and bismuth-213 and certain beta emitting radiopharmaceuticals in conjunction with monoclonal antibodies. the company’s lead radiopharmaceutical iomab™-b will be used in preparing patients for hematopoietic stem cell transplant, commonly referred to as bone marrow transplant. the company is preparing a single, pivotal, multicenter phase 3 clinical study of iomab™-b in refractory and relapsed acute myeloid leukemia (aml) patients over the age of 55 with a primary endpoint of durable complete remission. the company’s second program, actimab-a, is continuing its clinical development in a phase 1/2 trial for newly diagnosed aml patients o

Organization	Actinium Pharmaceuticals Inc
Employees	49
CEO	Mr. Sandesh C. Seth M.B.A., M.S.
Industry	Health Technology

Management People of Actinium Pharmaceuticals Inc

Name	Title
Mr. Sandesh C. Seth M.B.A., M.S.	Chairman & CEO
Mr. Steven O'Loughlin BS	CFO & Corporate Secretary
Dr. Paul Diamond Esq., Ph.D.	Vice President of Patent & Legal Counsel
Dr. Avinash Desai M.D.	Chief Medical Officer
Ms. Jenny Hsieh	Chief Strategy Officer
Ms. Sunitha Lakshminarayanan	Senior VP, Head of CMC & Product Development
Ms. Caroline Yarbrough	Chief Commercial Officer
Ms. Lynn M. Bodarky M.B.A.	Chief Business Officer
Mr. J. C. Simeon	Executive Director of Quality Assurance
Dr. Madhuri Vusirikala M.D.	Vice President of Clinical Development BMT & Cellular Therapy

Important FAQs about investing in Actinium Pharmaceuticals Inc from India :

What is Actinium Pharmaceuticals Inc share price today?

Actinium Pharmaceuticals Inc (ATNM) share price today is $1.36.

Can Indians buy Actinium Pharmaceuticals Inc shares?

Yes, Indians can invest in the Actinium Pharmaceuticals Inc (ATNM) from India.

With INDmoney, you can buy Actinium Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Actinium Pharmaceuticals Inc at zero transaction cost.

How can I buy Actinium Pharmaceuticals Inc shares from India?

It is very easy to buy Actinium Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Actinium Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Actinium Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Actinium Pharmaceuticals Inc stocks?

To start investing in Actinium Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.